ARCHIVES

Two Drugs Slow Progress Of Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency

April 19, 1996

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

In Brief: Senate Subcommittee Recommends $1 .52 Billion

September 25, 1987